Data laporan keuangan perusahaan tbk full#
include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially).retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article.for your employer, if the article is a ‘work for hire’, made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g.present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting.make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g.make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use.As an author you (or your employer or institution) may do the following: Retained Rights/Terms and Conditions of Publicationġ. Keywords: Financial Performance, Pharmaceutical Companies, Covid-19 Article Details before the pandemic or during the pandemic. also the same, there are significant differences based on liquidity ratios, solvency ratios, activity ratios and profitability ratios. based on liquidity ratios, solvency ratios, activity ratios and profitability ratios. The results of this study indicate that there are significant differences in PT. obtained from the official website of the Indonesia Stock Exchange (IDX), namely Then processed using the SPSS Version 16.0 application and the test used in this study is a comparative test, namely the Wilcoxon Sign Test. Data collection techniques used are documentation techniques on financial reports published by PT. This type of research is quantitative research with secondary data analysis and uses a comparative approach method. before the pandemic and during the covid-19 pandemic. This study aims to determine whether there are differences in the financial performance of PT. Kalbe Farma Tbk designates sales progress through an increase in life, genuine benefit progress through a downturn, and an increase in sales progress through an increasing life, although listed companies have the opportunity to go through a downturn, they can still live a life of good progress.The Covid-19 pandemic has an impact on the economic sector which has resulted in companies experiencing a decline in financial performance. The ratio of progress to the financial power of PT Indo Farma Tbk in the 2019-2020 period was also followed by PT. The profitability ratio of PT Kalbe Farma Tbk's financial power in the era of The 2019-2020 period represents the return on assets (ROA) as part of the supporting measure, and the return on equity (ROE) absorbs the part in the said-help measure, although the start of the 2020 period is likely to undergo a downturn. The solvency ratio of PT Kalbe Farma Tbk's financial power for the 2019-2020 period intended that the debt to asset ratio absorb the helping measure, and the debt to equity ratio absorb the helping measure because it has a low excess profit.
The results of the study show that the liquidity ratio of the financial power of PT Merck Indonesia Tbk for the 2019-2020 period is intended for the current ratio to absorb a share in the size, which is quite helpful in balancing the addition of other pharmaceutical companies. The previous ones are growth ratio and valuation ratio.
The ratio analysis used in this study includes analysis of liquidity, solvency, activity and profitability ratios, as well as additional ratios from researchers. The type of data used is secondary data obtained from the Indonesia Stock Exchange, namely the financial statements of the Pharmaceutical Sub-Sector Companies from 2019 to 2020.
The approach method used is a quantitative descriptive approach. This study aims to determine the improvement of financial performance during the pandemic in the pharmaceutical sector listed on the Indonesia Stock Exchange (IDX).